Intestinal bacteria may be able to make anti-cancer drugs more effective

MP 'bacteria in the intestines may become a part of some cancer treatments in one day. When you do a lot of research has included a number of specific microbes into its many rats disease serious skin cancer, they found microbes that help increase the effectiveness of cancer treatment with chemotherapy.

Small microbes whose cells only a few hundred million million (Tri) in your gut is probably more than the number of cells your whole body up to 10 times.

Most of these microbes may be useful for some of us. The efforts of all the science right now is focused on the analysis to find out whether the variety microbes or other words that these microbiota can do some things.

The most recent study published in the journal Science suggested that a number of microbes can help fight cancer.

In the study on mice, Tom Guyjewsky doctors specializing in cancer tumors and colleagues at the University of Chicago found found that microbes in the intestines of mice created by creating a strong immune response against skin cancer which is a vicious disease.

When these mice were treated with chemotherapy tumor PD L-1 of them has narrowed remarkable and almost gone.

Guyjewsky said: 'Now we have a patient that their tumors were completely eradicated not only know that they may be stable this year. And this is just for a handful of patients. If we can find the key to boost the immune response, we may be able to increase the number of patients who can get a good immune response against their tumor.

Initially many researchers noted that mice obtained from a laboratory's response the immune system against tumors of the small skin cancers. And there are also mice from other laboratories have a weak response against the tumor.

However, when these mice were placed in mixed together researchers found that tumors in mice all decreased.

These researchers believe that living together can transfer intestinal Group in a number of useful species rodents who did not benefit from the use of PD L-1.

Many observers farewell transferred from mice that the immune system responds to a variety mice A weak immune system's response to the analysis. some time later, they found that tumors grow much slower than before both among rats.

A type of intestinal bacteria called bacterial flagship policy (Bifobacterium) seems particularly useful.

Guyjewsky said the flagship policy bacteria (Bifobacterium) as effective as the drug PD L-1, and when it is used with it can create a drug treatment that has the potential for some cancers including lung cancer, head and neck.

Guyjewsky said antibody drugs are very expensive, but if they use drugs, with products made from human gut microbes can have more access to treatment by taking these antibodies.

Guyjewsky said: These drugs may be easier to export to developing countries when Think ahead. these expensive treatments that you imagine will not be there for a while But developing countries such as Probiotic can be cheaper and easier to find.

Some organic microbial probiotic called being sold on the market.

But Guyjewsky warned of the use of these microbes, because some medications can make the immune system weakened, making Cancer wider spread or make anti-cancer drugs weaken tumor effect.